Tudor Investment Corporation »

Soleno Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Soleno Therapeutics

Apr 2024May 2024Jun 2024Jul 2024Aug 2024Sep 2024Oct 20241M1.5M2M20k30k40k
Value ($)Share countHistorical SLNO position of Tudor Investment Corporation Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 42k 50.49
2024-06-30 $722k 18k 40.80
2024-03-31 $693k 16k 42.80

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
iShares Bitcoin Trust ETF - US ETP Exchange-Traded Fund (IBIT)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Utilities Select Sector Spdr Fund - US ETP ETF Option Put Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P Regional Banking Etf - US ETP ETF Option Call Option (KRE)
Vaneck Semiconductor Etf - US ETP ETF Option Call Option (SMH)
Nvidia Corp - US Equity (NVDA)
Ishares Core S&P 500 Etf - US ETP Exchange-Traded Fund (IVV)
Kellanova - US Equity (K)
Apple Inc - US Equity (AAPL)
Microsoft Corp - US Equity (MSFT)
Palantir Technologies Inc - US Equity (PLTR)

View all positions for Tudor Investment Corporation

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics